News Articles Tagged: Treatment-Resistant Depression

GLYX-13: A New Hope for Treatment-Resistant Depression

Discussing GLYX-13's potential for treating treatment-resistant depression, this article highlights its unique NMDA receptor modulation and favorable preclinical outcomes.

The Role of Agomelatine in Treating Treatment-Resistant Depression: A NINGBO INNO PHARMCHEM CO.,LTD. Perspective

Explore how NINGBO INNO PHARMCHEM CO.,LTD. supplies Agomelatine, a key pharmaceutical intermediate for tackling treatment-resistant depression and improving patient outcomes.